Research
Since our founding in 1906, American Leprosy Missions has worked to find new solutions to CURE diseases like leprosy, better CARE for those affected and actually END these devastating diseases.
From pioneering leprosy drug treatment using diasone in 1946, to developing special farm tools and equipment for anesthetic hands in the 1970s, to piloting multi-drug therapy for leprosy with the Philippines Department of Health in the 1980s, to launching research into the world’s first leprosy-specific vaccine in 2002, ALM has continually sought new ways to create sustainable, positive impact for people affected by leprosy and related diseases.
We continue to accelerate the exploration and application of innovative solutions in order to heal suffering people and restore them to lives of dignity and hope.
Some Pioneering Projects Include:
NTD Innovation Prize
American Leprosy Missions launched the NTD Innovation Prize in 2019 to identify and support innovators with creative ideas to solve some of the most challenging issues posed by NTDs across the globe.
Between 2019 and 2023, we received 166 abstracts from around the world, resulting in over $180,000 awarded to eight projects.